Publicacions en col·laboració amb investigadors/es de Ludwig Maximilian University of Munich (5)

2024

  1. European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

    Journal of Clinical Oncology, Vol. 42, Núm. 16, pp. 1875-1880

  2. Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

    Leukemia, Vol. 38, Núm. 8, pp. 1722-1730

2020

  1. IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma

    Haematologica

2019

  1. Spectrum and functional validation of PSMB5 mutations in multiple myeloma

    Leukemia, Vol. 33, Núm. 2, pp. 447-456

2018

  1. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

    The Lancet Oncology, Vol. 19, Núm. 6, pp. 747-757